title: CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.
abstract: The expression of osteopontin (OPN), CD44 variants, and integrins has been correlated with tumorigenesis and metastasis. Here we show that these proteins cooperate to enhance cell motility. First, we demonstrate that several different CD44 variants bind to OPN in an arginine-glycineaspartic acid-independent manner, but that the standard form of CD44 does not. These CD44 variants bind to both the amino- and COOH-terminal portions of OPN independently of the arginine-glycine-aspartic acid sequence, suggesting that multiple domains on OPN can be bound by the CD44 variants. Antibodies directed against the integrin beta1 subunit are able to inhibit this binding. The binding of CD44 variants to OPN is significantly augmented by both anti-CD44s and anti-CD44v antibodies. This augmentation by anti-CD44 antibodies is OPN specific and, again, can be blocked by anti-beta1 antibodies. Finally, we show that OPN binding by CD44 variants/beta1-containing integrins promotes cell spreading, motility, and chemotactic behavior.
authors.affiliation: Section of Immunopathogenesis, Institute of Immunological Science, Hokkaido University, Sapporo, Japan.
authors.forename: Y U
authors.initials: YU
authors.lastname: Katagiri
authors.forename: J
authors.initials: J
authors.lastname: Sleeman
authors.forename: H
authors.initials: H
authors.lastname: Fujii
authors.forename: P
authors.initials: P
authors.lastname: Herrlich
authors.forename: H
authors.initials: H
authors.lastname: Hotta
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
authors.forename: S
authors.initials: S
authors.lastname: Chikuma
authors.forename: H
authors.initials: H
authors.lastname: Yagita
authors.forename: K
authors.initials: K
authors.lastname: Okumura
authors.forename: M
authors.initials: M
authors.lastname: Murakami
authors.forename: I
authors.initials: I
authors.lastname: Saiki
authors.forename: A F
authors.initials: AF
authors.lastname: Chambers
authors.forename: T
authors.initials: T
authors.lastname: Uede
mesh_terms: D000818:Animals; D001120:Arginine; D001224:Aspartic Acid; D001665:Binding Sites; D002633:Chemotaxis / Q000187:drug effects / Q000502:physiology*; D005998:Glycine; D018960:Hyaluronan Receptors / Q000737:chemistry / Q000502:physiology*; D019012:Integrin beta1 / Q000502:physiology*; D053495:Osteopontin; D011485:Protein Binding; D051381:Rats; D012795:Sialoglycoproteins / Q000494:pharmacology / Q000502:physiology*; D014407:Tumor Cells, Cultured
chemical_list: D018960:Hyaluronan Receptors; D019012:Integrin beta1; D012795:Sialoglycoproteins; C506897:Spp1 protein, rat; D053495:Osteopontin; D001224:Aspartic Acid; D001120:Arginine; D005998:Glycine